GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Cash Flow for Dividends

U2Bio Co (XKRX:221800) Cash Flow for Dividends : ₩-1,263 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Cash Flow for Dividends?

U2Bio Co's cash flow for dividends for the six months ended in Dec. 2023 was ₩0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,263 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

U2Bio Co's quarterly payment of dividends increased from Dec. 2022 (₩0 Mil) to Jun. 2023 (₩-1,263 Mil) but then declined from Jun. 2023 (₩-1,263 Mil) to Dec. 2023 (₩0 Mil).

U2Bio Co's annual payment of dividends increased from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩-758 Mil) and increased from Dec. 2022 (₩-758 Mil) to Dec. 2023 (₩-1,263 Mil).

U2Bio Co Cash Flow for Dividends Historical Data

The historical data trend for U2Bio Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Cash Flow for Dividends Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only - - - -757.65 -1,262.76

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Cash Flow for Dividends -757.65 - -1,262.76 -

U2Bio Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩-1,263 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U2Bio Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Cash Flow for Dividends
Comparable Companies
XKRX:031860 XKRX:347740 XKRX:245620 XKRX:086040 XKRX:229000 XKRX:253840 XKRX:122310 XKRX:363250 XKRX:950200 XKRX:109820 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
Website
http://www.u2bio.co.kr
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines